Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 1027 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Shan J, Chouchane A, Mokrab Y, Saad M, Boujassoum S, Sayaman RW, Ziv E, Bouaouina N, Remadi Y, Gabbouj S et al..  2019.  Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications.. Front Oncol. 9:1328.
Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang X-Y.  2005.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.. Proc Natl Acad Sci U S A. 102(10):3772-6.
Seshadri C, Flynn JAL, Maiello P, Schnappinger D, Wilkinson RJ, Gordon SB, Mwandumba HC, Jambo KC, Hoft DF, Rubin EJ et al..  2026.  Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials.. Lancet Microbe. :101278.
Seimon TA, Kim M-J, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker L-G, Kaplan G, Nathan C, Tabas I et al..  2010.  Induction of ER stress in macrophages of tuberculosis granulomas.. PLoS One. 5(9):e12772.
Seehus CR, Aliahmad P, de la Torre B, Iliev ID, Spurka L, Funari VA, Kaye J.  2015.  The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor.. Nat Immunol. 16(6):599-608.
Seamons A, Sutton J, Bai D, Baird E, Bonn N, Kafsack BFC, Shabanowitz J, Hunt DF, Beeson C, Goverman J.  2003.  Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity.. J Exp Med. 197(10):1391-7.
Schwer B, Garg A, Jacewicz A, Shuman S.  2021.  Genetic screen for suppression of transcriptional interference identifies a gain-of-function mutation in Pol2 termination factor Seb1.. Proc Natl Acad Sci U S A. 118(33)
Schwer B, Sanchez AM, Shuman S.  2020.  Inactivation of fission yeast Erh1 de-represses pho1 expression: evidence that Erh1 is a negative regulator of prt lncRNA termination.. RNA. 26(10):1334-1344.
Schwer B, Lehman K, Saha N, Shuman S.  2001.  Characterization of the mRNA capping apparatus of Candida albicans.. J Biol Chem. 276(3):1857-64.
Schwer B, Meszaros T.  2000.  RNA helicase dynamics in pre-mRNA splicing.. EMBO J. 19(23):6582-91.
Schwer B, Garg A, Sanchez AM, Bernstein MA, Benjamin B, Shuman S.  2022.  Cleavage-Polyadenylation Factor Cft1 and SPX Domain Proteins Are Agents of Inositol Pyrophosphate Toxicosis in Fission Yeast.. mBio. 13(1):e0347621.
Schwer B, Sawaya R, C Ho K, Shuman S.  2004.  Portability and fidelity of RNA-repair systems.. Proc Natl Acad Sci U S A. 101(9):2788-93.
Schwer B, Prucker I, Sanchez AM, Babor J, Jessen HJ, Shuman S.  2025.  Tandem inactivation of inositol pyrophosphatases Asp1, Siw14, and Aps1 illuminates functional redundancies in inositol pyrophosphate catabolism in fission yeast.. mBio. 16(5):e0038925.
Schwer B.  2001.  A new twist on RNA helicases: DExH/D box proteins as RNPases.. Nat Struct Biol. 8(2):113-6.
Schwer B, Innokentev A, Sanchez AM, Garg A, Shuman S.  2024.  Suppression of inositol pyrophosphate toxicosis and hyper-repression of the fission yeast PHO regulon by loss-of-function mutations in chromatin remodelers Snf22 and Sol1.. mBio. 15(7):e0125224.
Schubert P, Schnappinger D, Pfleiderer K, Hillen W.  2001.  Identification of a stability determinant on the edge of the Tet repressor four-helix bundle dimerization motif.. Biochemistry. 40(11):3257-63.
Schrader SM, Botella H, Jansen R, Ehrt S, Rhee K, Nathan C, Vaubourgeix J.  2021.  Multiform antimicrobial resistance from a metabolic mutation.. Sci Adv. 7(35)
Schrader SM, Vaubourgeix J, Nathan C.  2020.  Biology of antimicrobial resistance and approaches to combat it.. Sci Transl Med. 12(549)
Schorcht A, Cottrell CA, Pugach P, Ringe RP, Han AX, Allen JD, van den Kerkhof TLGM, Seabright GE, Schermer EE, Ketas TJ et al..  2022.  The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.. J Virol. 96(1):e0155221.
Schoolnik GK, Voskuil MI, Schnappinger D, Yildiz FH, Meibom K, Dolganov NA, Wilson MA, Chong KH.  2001.  Whole genome DNA microarray expression analysis of biofilm development by Vibrio cholerae O1 E1 Tor.. Methods Enzymol. 336:3-18.
Schoggins JW, Nociari M, Philpott N, Falck-Pedersen E.  2005.  Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.. J Virol. 79(18):11627-37.
Schoggins JW, Falck-Pedersen E.  2006.  Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.. J Virol. 80(21):10634-44.
Schoggins JW, Gall JGD, Falck-Pedersen E.  2003.  Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.. J Virol. 77(2):1039-48.
Schoggins JW, Falck-Pedersen E.  2009.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.. Virology. 395(1):10-20.
Schneider S, Campodonico E, Schwer B.  2004.  Motifs IV and V in the DEAH box splicing factor Prp22 are important for RNA unwinding, and helicase-defective Prp22 mutants are suppressed by Prp8.. J Biol Chem. 279(10):8617-26.